查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370966

呼吸道疾病測試市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按測試類型、按應用、最終用戶、地區和競爭細分

Respiratory Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年，全球呼吸道疾病檢測市場估值達到 60.1 億美元，預計在整個預測期內強勁擴張，預計年複合成長率 (CAGR) 為 5.72%，到 2028 年預計將達到 83.0 億美元。包括肺功能和相關過程的評估，統稱為呼吸診斷。這涉及一系列機械、影像和分子診斷測試，旨在檢測氣喘、慢性阻塞性肺病 (COPD)、肺癌、支氣管炎和肺纖維化等疾病。此領域應用的技術包括肺活量測定法、血氧測定法、經皮二氧化碳監測、鼻吸氣壓 (SNIP)、胸部 X 光檢查和電腦斷層掃描 (CT) 掃描。在特定情況下，還可以進行睡眠研究來診斷睡眠呼吸中止症和夜間通氣不足。

主要市場促進因素：

呼吸系統疾病的負擔日益加重：呼吸系統疾病盛行率的上升是市場成長的關鍵驅動力。吸菸、飲酒、久坐的生活方式和壓力等因素增加了慢性阻塞性肺病和肺癌等其他嚴重呼吸道疾病的病例數。此外，呼吸診斷測試技術的進步，包括用於慢性阻塞性肺病診斷和門診管理的物聯網（IoT）和人工智慧（AI），對市場擴張產生了積極影響。私立醫院和醫療中心對呼吸診斷設備的需求不斷成長。政府和非政府組織 (NGO) 也在努力提高獲得優質醫療保健的機會，促進市場成長。呼吸道症狀是到基層醫療中心就診的主要原因之一，凸顯了呼吸道疾病負擔日益增加及其對呼吸道疾病檢測需求的影響。

市場概況
預測期 2024-2028
2022 年市場規模 60.1億美元
2028 年市場規模 83億美元
2023-2028 年年複合成長率 5.72%
成長最快的細分市場 肺癌
最大的市場 北美洲

測試設備和模式的技術進步：市場正在見證技術進步的巨大牽引力。該領域的主要參與者專注於人工智慧 (AI) 和機器學習技術的開發，以最佳化治療方案並提高患者治療效果。例如，Respira Labs 推出了一款名為 Sylvee 的人工智慧穿戴式設備，用於監測肺功能，從而實現慢性阻塞性肺病的早期診斷和管理。收購也促進了市場成長，CAIRE Inc. 收購 MGC Diagnostics Holdings 以實現產品多元化並鞏固其市場地位就體現了這一點。

老年人口不斷增加：全球老年人口預計將激增，隨之而來的是由於呼吸系統的生理變化而導致的呼吸道感染的易感性。由於老年人的呼吸系統疾病更為嚴重，早期發現並了解這些疾病對於改善患者的治療效果至關重要。因此，老年人口的增加推動了呼吸道疾病檢測市場的成長。

主要市場挑戰：

高成本和缺乏熟練的專業人員：診斷程序成本高昂，技術的快速進步導致合格專家的短缺。這種短缺阻礙了程序的正確執行，包括儀器的處理和測試的執行，從而阻礙了市場的成長。

有限的報銷政策：全球範圍內報銷政策不足或不存在可能會阻礙診斷測試的需求，從而限制市場成長。如果沒有適當的報銷，患者可能會猶豫是否接受呼吸系統疾病檢測，從而導致診斷和治療的延遲，特別是在亞太地區。

主要市場趨勢：

床邊檢測 (POCT) 擴展：呼吸系統疾病床邊檢測的擴展有助於在各種醫療機構中進行快速、方便的檢測。 POCT 設備可快速提供結果，有助於及時診斷和監測，特別是在資源有限的環境中。

人工智慧 (AI) 的整合：人工智慧驅動的演算法提高了呼吸系統疾病測試結果的準確性和解釋，從而實現更精確的診斷和個人化的治療建議。人工智慧可以識別人類專家可能會錯過的模式和相關性，從而徹底改變呼吸系統疾病的診斷。

細分洞見：

測試類型洞察：市場分為影像測試、機械測試和體外診斷測試。體外診斷測試因其廣泛採用和功效而佔據主導地位。由於對精確診斷方法的需求增加和成像技術的進步，成像測試正在快速成長。

最終用戶見解：醫院憑藉全面的護理和多學科方法佔據市場主導地位。在門診護理趨勢不斷成長和對獨立診斷服務的需求的推動下，診斷中心正在迅速發展。

區域洞察：由於先進的醫療基礎設施、醫療支出和呼吸道疾病的流行，北美保持主導地位。亞太地區是成長最快的地區，其推動因素包括龐大的人口基數、城市化進程、對呼吸道疾病的認知以及醫療基礎設施的改善。

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球呼吸系統疾病檢測市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依測試類型（成像測試、機械測試和體外診斷測試）
    • 按應用（慢性阻塞性肺病、肺癌、氣喘、結核病）
    • 按最終使用者（醫院、診斷中心等）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美呼吸道疾病檢測市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按測試類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲呼吸道疾病檢測市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按測試類型
    • 按應用
    • 按最終用戶
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太呼吸系統疾病檢測市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按測試類型
    • 按應用
    • 按最終用戶
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲呼吸道疾病檢測市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按測試類型
    • 按應用
    • 按最終用戶
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲呼吸道疾病檢測市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按測試類型
    • 按應用
    • 按最終用戶
  • MEA：國家分析
    • 南非呼吸道疾病檢測
    • 沙烏地阿拉伯呼吸道疾病檢測
    • 阿拉伯聯合大公國呼吸道疾病檢測

第 11 章：市場動態

第 12 章：市場趨勢與發展

第 13 章：全球呼吸系統疾病檢測市場：SWOT 分析

第14章：競爭格局

  • 商業概覽
  • 服務產品
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Beckton Dickinson and Company
    • Koninklijke Philips NV
    • ResMed Inc.
    • Medtronic PLC
    • Carestream Health
    • MG Diagnostic Corporation
    • Abbott Laboratories
    • ThermoFisher Scientific
    • Biomerieux
    • QIAGEN

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄
Product Code: 4698

The Global Respiratory Disease Testing Market achieved a valuation of USD 6.01 Billion in 2022 and is poised for robust expansion throughout the forecast period with a projected Compound Annual Growth Rate (CAGR) of 5.72% and expected to reach USD 8.30 Billion through 2028. This market encompasses the evaluation of lung function and associated processes, collectively known as respiratory diagnostics. This involves a spectrum of mechanical, imaging, and molecular diagnostic tests aimed at detecting conditions such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. The techniques applied in this domain include spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray, and computed tomography (CT) scan. In specific cases, sleep studies may also be conducted to diagnose sleep apnea and nocturnal hypoventilation.

Key Market Drivers:

Growing Burden of Respiratory Diseases: The rising prevalence of respiratory diseases acts as a pivotal driver for market growth. Factors such as increased smoking, alcohol consumption, sedentary lifestyles, and stress have contributed to the escalation of COPD cases and other severe respiratory conditions like lung cancer. Moreover, advancements in respiratory diagnostic testing technologies, including Internet of Things (IoT) and Artificial Intelligence (AI) for COPD diagnosis and outpatient management, have positively influenced market expansion. Private hospitals and healthcare centers exhibit escalating demand for respiratory diagnostic devices. Government and non-governmental organizations (NGOs) are also striving to enhance access to quality healthcare, fostering market growth. Respiratory symptoms are among the primary reasons for seeking medical consultation in primary healthcare centers, underscoring the growing burden of respiratory diseases and their impact on the demand for respiratory disease testing.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 6.01 Billion
Market Size 2028USD 8.30 Billion
CAGR 2023-20285.72%
Fastest Growing SegmentLung Cancer
Largest MarketNorth America

Technological Advancements in Testing Devices and Modalities: The market is witnessing significant traction from technological advancements. Key players in this arena are focusing on the development of Artificial Intelligence (AI) and machine learning technologies to optimize treatment protocols and enhance patient outcomes. For example, Respira Labs introduced an AI-powered wearable device named Sylvee for monitoring lung function, enabling early COPD diagnosis and management. Acquisitions are also contributing to market growth, as seen through CAIRE Inc.'s acquisition of MGC Diagnostics Holdings to diversify their offerings and consolidate their position in the market.

Increasing Geriatric Population: The global geriatric population is projected to surge, and with it, the susceptibility to respiratory infections due to physiological changes in the respiratory system. As respiratory diseases are more severe in the elderly, early detection and understanding of these conditions are crucial for improving patient outcomes. The rising elderly population thus fuels the growth of the respiratory disease testing market.

Increasing Government Initiatives: Government initiatives are pivotal in fostering advancements and growth in the respiratory disease testing market. National action plans focused on respiratory diseases, surveillance programs, research funding, and public awareness campaigns create an environment conducive to research, innovation, and improved healthcare infrastructure. These initiatives play a vital role in addressing the global burden of respiratory diseases and enhancing patient outcomes.

Key Market Challenges:

High Cost and Lack of Skilled Professionals: Diagnostic procedures come with a substantial cost, and the rapid advancement of technology has led to a shortage of qualified specialists. This shortage hampers the proper execution of procedures, including the handling of instruments and execution of tests, thereby impeding market growth.

Limited Reimbursement Policies: Inadequate or nonexistent reimbursement policies globally can hinder the demand for diagnostic tests, limiting market growth. Without proper reimbursement, patients may hesitate to undergo respiratory disease testing, leading to delayed diagnosis and treatment, particularly in the Asia Pacific region.

Key Market Trends:

Point-of-Care Testing (POCT) Expansion: The expansion of point-of-care testing for respiratory diseases facilitates rapid and convenient testing in various healthcare settings. POCT devices provide quick results, aiding timely diagnosis and monitoring, particularly in resource-limited environments.

Integration of Artificial Intelligence (AI): AI-driven algorithms enhance the accuracy and interpretation of respiratory disease test results, leading to more precise diagnoses and personalized treatment recommendations. AI can identify patterns and correlations that human experts might miss, revolutionizing respiratory disease diagnostics.

Segmental Insights:

Test Type Insights: The market is categorized into Imaging Tests, Mechanical Tests, and In-vitro Diagnostic Tests. In-vitro Diagnostic Tests are dominant due to their broad adoption and efficacy. Imaging Tests are experiencing rapid growth due to increased demand for precise diagnostic methods and advancements in imaging technology.

End User Insights: Hospitals dominate the market due to their comprehensive care and multidisciplinary approach. Diagnostic centers are growing rapidly, fueled by the increasing trend towards outpatient care and demand for standalone diagnostic services.

Regional Insights: North America maintains dominance due to advanced healthcare infrastructure, healthcare expenditure, and prevalence of respiratory diseases. Asia Pacific is the fastest growing region, driven by a large population base, urbanization, awareness about respiratory diseases, and improving healthcare infrastructure.

Key Market Players

  • Beckton Dickinson and Company
  • Koninklijke Philips N.V.
  • ResMed Inc.
  • Medtronic PLC
  • Carestream Health
  • MG Diagnostic Corporation
  • Abbott Laboratories
  • ThermoFisher Scientific
  • Biomerieux
  • QIAGEN

Report Scope:

In this report, the Global Respiratory Disease Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Respiratory Disease Testing Market, By Test Type:

  • Imaging Tests
  • Mechanical Tests
  • In-vitro Diagnostic Tests

Respiratory Disease Testing Market, By Application:

  • COPD
  • Lung Cancer
  • Asthma
  • Tuberculosis

Respiratory Disease Testing Market, By End User:

  • Hospitals
  • Diagnostic Centres
  • Others

Respiratory Disease Testing Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Disease Testing Market.

Available Customizations:

  • Global Respiratory Disease Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Respiratory Disease Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Imaging Tests, Mechanical Tests, and In-vitro Diagnostic Tests)
    • 5.2.2. By Application (COPD, Lung Cancer, Asthma, Tuberculosis)
    • 5.2.3. By End User (Hospitals, Diagnostic Centres, and Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. North America Respiratory Disease Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Respiratory Disease Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Respiratory Disease Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Respiratory Disease Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Respiratory Disease Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Application
    • 7.2.3. By End User
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Respiratory Disease Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Respiratory Disease Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Respiratory Disease Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France Respiratory Disease Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Respiratory Disease Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Respiratory Disease Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Application
    • 8.2.3. By End User
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Respiratory Disease Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Respiratory Disease Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Respiratory Disease Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Respiratory Disease Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Respiratory Disease Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Respiratory Disease Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Application
    • 9.2.3. By End User
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Respiratory Disease Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Respiratory Disease Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Respiratory Disease Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Respiratory Disease Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Application
    • 10.2.3. By End User
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Respiratory Disease Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Respiratory Disease Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Respiratory Disease Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

12. Market Trends & Developments

13. Global Respiratory Disease Testing Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Services Offerings
  • 14.3. Recent Developments
  • 14.4. Key Personnel
  • 14.5. SWOT Analysis
    • 14.5.1. Beckton Dickinson and Company
    • 14.5.2. Koninklijke Philips N.V.
    • 14.5.3. ResMed Inc.
    • 14.5.4. Medtronic PLC
    • 14.5.5. Carestream Health
    • 14.5.6. MG Diagnostic Corporation
    • 14.5.7. Abbott Laboratories
    • 14.5.8. ThermoFisher Scientific
    • 14.5.9. Biomerieux
    • 14.5.10. QIAGEN

15. Strategic Recommendations

16. About Us & Disclaimer